Epigenetics & Chromatin is a peer-reviewed open access scientific journal published by BioMed Central that covers the biology of epigenetics and chromatin.
Scope Epigenetics & Chromatin is a peer-reviewed open access scientific journal that publishes research related to epigenetic inheritance and chromatin-based interactions. First published in 2008 by BioMed Central, its overall aim is to understand the regulation of gene and chromosomal elements during the processes of cell division, cell differentiation, and any alterations in the environment. To date, 13 volumes have been published.
Usage
As of October 2020, there has been over 340,000 downloads and over 750 Altmetric mentions.
Metrics
Impact factor According to Journal Citation Reports, it received an impact factor of 4.237 in 2019. Its current SCImago Journal Rank is 2.449.
Citation impact Its 2-year and 5-year citation impact factor is 4.237 and 4.763, respectively. Its Source Normalized Impact per Paper (SNIP) is 0.896.
Editors Its current Journal Authority Factor (JAF) is 111.5.
Editors-in-Chief + Editor Institution Frank Grosveld Erasmus University Medical Center, Netherlands Steven Henikoff Fred Hutchinson Cancer Research Center, USA
Editorial Board + Editor Institution Julie Ahringer The Gurdon Institute, University of Cambridge, UK Juan Ausió University of Victoria, Canada Shelley Berger The Wistar Institute, USA Timothy Bestor Columbia University, USA Yamini Dalal National Cancer Institute, USA Elzo de Wit Netherlands Cancer Institute, The Netherlands Jerome Dejardin Institute of Human Genetics, France Anne Ferguson-Smith University of Cambridge, UK Amanda Fisher Imperial College London, UK John Greally Albert Einstein College of Medicine, USA Shiv Grewal National Institutes of Health, USA Joost Gribnau Erasmus University Medical Center, Netherlands Gordon Hager National Cancer Institute, USA Steven Jacobsen University of California, Los Angeles, USA Albert Jeltsch University of Stuttgart, Germany Paul Kaufman University of Massachusetts Medical School, USA William Kelly Emory University, USA Siavash Kurdistani University of California, Los Angeles, USA Colin Logie Radboud University Medical Centre, The Netherlands Frank Lyko German Cancer Research Center, Germany Kazuhiro Maeshima National Institute of Genetics, Japan Valerio Orlando King Abdullah University of Science and Technology, Saudi Arabia Vincenzo Pirotta Rutgers University, USA Ana Pombo Max Delbrueck Centre, Germany Oliver Rando Harvard FAS Center for Systems Biology, USA Jasper Rine University of California, Berkeley, USA Wendy Robinson BC Children's Hospital Research Institute, Canada Yang Shi Harvard Medical School, USA David Spector Cold Spring Harbor Laboratory, USA Brian Strahl University of North Carolina, USA Azim Surani The Wellcome Trust & Cancer Research UK, UK David Tremethick Australian National University, Australia Jessica Tyler MD Anderson Cancer Center, USA Bas van Steensel The Netherlands Cancer Institute, Netherlands Jörn Walter Universität des Saarlandes, Germany Jerry Workman Stowers Institute for Medical Research, USA Anton Wutz ETH Zurich, Switzerland Rui-ming Xu Chinese Academy of Sciences, China Yi Zhang Harvard Medical School, USA
Submission guidelines
Current submission guidelines are as follows:
Prior to submitting
Submitters must ensure that Epigenetics & Chromatin is the most suitable journal for the proposed article in addition to understanding of the costs, funding options, and copyright agreement associated with submission. Accuracy and readability of the manuscript must also be considered.
During the submission process
The manuscript must follow all formatting rules which authors must read, understand and accept.
After successful submission
Authors should review the peer-review policy. Authors should also be familiar with the process of manuscript transfers to a different journal, as well as how to promote the publication.
Speed of the submission process On average, it takes 53 days to reach a decision for reviewed manuscripts and 35 days for all manuscripts. The process of acceptance takes an average of 112 days after submission. After acceptance, it takes an average of 16 days for an article to be published.
Indexing services After successful publication in Epigenetics & Chromatin, articles are also included in:
Biological Abstracts Chemical Abstracts (CAS) Citebase Directory of Open Access Journals (DOAJ) Embase EMBiology MEDLINE OAIster PubMed PubMed Central (PMC) Science Citation Index Expanded Scopus SOCOLAR Zetoc (operated by Jisc)
Notable publications As of October 2020, the most accessed articles are: Chromatin accessibility: a window into the genome (Tsompana & Buck, 2014) Constitutive heterochromatin formation and transcription in mammals (Saksouk et al., 2015) Chromatin structure and DNA damage repair (Dinant et al., 2008) Profiling genome-wide DNA methylation (Yong et al., 2016) Additional annotation enhances potential for biologically relevant analysis of the Illumina Infinium HumanMethylation450 BeadChip Array (Price et al., 2013)
References
External links